Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Caligan Partners LP | 8.16M | $30.0M | 5.87% | +3.19M | 2026-06-30 |
| SAMSARA BIOCAPITAL, LLC | 6.31M | $23.0M | 4.54% | +1.12M | 2026-06-30 |
| Paradigm Biocapital Advisors LP | 4.00M | $15.0M | 2.87% | -- | 2026-06-30 |
| ANDERA PARTNERS | 3.63M | $13.0M | 2.61% | +1.81M | 2026-06-30 |
| ADAR1 Capital Management, LLC | 3.61M | $13.0M | 2.59% | +1.43M | 2026-06-30 |
| MILLENNIUM MANAGEMENT LLC | 3.51M | $13.0M | 2.52% | +524.6K | 2026-06-30 |
| Nantahala Capital Management, LLC | 2.69M | $10.0M | 1.93% | -- | 2026-06-30 |
| Trails Edge Capital Partners, LP | 2.66M | $10.0M | 1.91% | -- | 2026-06-30 |
| FRANKLIN RESOURCES INC | 2.64M | $9.0M | 1.90% | +181.0K | 2026-06-30 |
| Squadron Capital Management LLC | 2.44M | $9.0M | 1.75% | +1.90M | 2026-06-30 |
